116 related articles for article (PubMed ID: 37245583)
21. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells.
Zhang X; Gu L; Li J; Shah N; He J; Yang L; Hu Q; Zhou M
Cancer Res; 2010 Dec; 70(23):9895-904. PubMed ID: 20935220
[TBL] [Abstract][Full Text] [Related]
22. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
23. The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells.
Raza S; Ohm JE; Dhasarathy A; Schommer J; Roche C; Hammer KD; Ghribi O
Mol Cell Biochem; 2015 Dec; 410(1-2):187-95. PubMed ID: 26350565
[TBL] [Abstract][Full Text] [Related]
24. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins.
Soares J; Raimundo L; Pereira NA; dos Santos DJ; Pérez M; Queiroz G; Leão M; Santos MM; Saraiva L
Pharmacol Res; 2015; 95-96():42-52. PubMed ID: 25814188
[TBL] [Abstract][Full Text] [Related]
25. Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs.
Dolfi SC; Jäger AV; Medina DJ; Haffty BG; Yang JM; Hirshfield KM
Cancer Lett; 2014 Aug; 350(1-2):52-60. PubMed ID: 24747123
[TBL] [Abstract][Full Text] [Related]
26. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
[TBL] [Abstract][Full Text] [Related]
27. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis.
Xu Y; Diao Y; Qi S; Pan X; Wang Q; Xin Y; Cao X; Ruan J; Zhao Z; Luo L; Liu C; Yin Z
Cell Signal; 2013 May; 25(5):1176-85. PubMed ID: 23357534
[TBL] [Abstract][Full Text] [Related]
29. [Effect of quercetin on glioma cell U87 apoptosis and feedback regulation of MDM2-p53].
Wang H; Yuan Z; Chen Z; Yao F; Hu Z; Wu B
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):686-9. PubMed ID: 24849437
[TBL] [Abstract][Full Text] [Related]
30. LncRNA PVT1 contributes to invasion and doxorubicin resistance of bladder cancer cells through promoting MDM2 expression and AURKB-mediated p53 ubiquitination.
Jiang X; Li H; Fang Y; Xu C
Environ Toxicol; 2022 Jun; 37(6):1495-1508. PubMed ID: 35213076
[TBL] [Abstract][Full Text] [Related]
31. Violacein induces apoptosis in human breast cancer cells through up regulation of BAX, p53 and down regulation of MDM2.
Alshatwi AA; Subash-Babu P; Antonisamy P
Exp Toxicol Pathol; 2016 Jan; 68(1):89-97. PubMed ID: 26521020
[TBL] [Abstract][Full Text] [Related]
32. Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K/AKT/mTOR signaling pathway.
Li LJ; Chai Y; Guo XJ; Chu SL; Zhang LS
Mol Med Rep; 2018 Jun; 17(6):7886-7892. PubMed ID: 29620275
[TBL] [Abstract][Full Text] [Related]
33. P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin.
Ma Y; Yuan R; Meng Q; Goldberg ID; Rosen EM; Fan S
Mol Cell Biol Res Commun; 2000 Feb; 3(2):122-8. PubMed ID: 10775510
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.
Rigatti MJ; Verma R; Belinsky GS; Rosenberg DW; Giardina C
Mol Carcinog; 2012 May; 51(5):363-78. PubMed ID: 21557332
[TBL] [Abstract][Full Text] [Related]
35. Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
Huun J; Gansmo LB; Mannsåker B; Iversen GT; Øvrebø JI; Lønning PE; Knappskog S
BMC Cell Biol; 2017 Apr; 18(1):17. PubMed ID: 28415963
[TBL] [Abstract][Full Text] [Related]
36. Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress.
Yang PM; Lin YT; Shun CT; Lin SH; Wei TT; Chuang SH; Wu MS; Chen CC
Sci Rep; 2013 Nov; 3():3219. PubMed ID: 24225777
[TBL] [Abstract][Full Text] [Related]
37. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
Zhang W; Zhong T; Chen Y
J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
[TBL] [Abstract][Full Text] [Related]
38. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation.
Pang XL; He G; Liu YB; Wang Y; Zhang B
World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162
[TBL] [Abstract][Full Text] [Related]
39. p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress.
López I; Tournillon AS; Nylander K; Fåhraeus R
Cell Cycle; 2015; 14(21):3373-8. PubMed ID: 26397130
[TBL] [Abstract][Full Text] [Related]
40. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
